Opinion on "Assessment of the risks to human health posed by certain chemicals in textiles", WS Atkins, Final report - Opinion adopted at the 17th CSTEE plenary meeting, Brussels, 5 September, 2000.
Context
The Commission's
attention has been drawn, by
the German Government, to the
possible need for restrictions
on the use of certain chemicals
in textile clothing in close
contact with the skin, notably
sensitising dispersive dyes and
trichlorobenzene. The aim of
the study by WS Atkins on the
risks posed by the substances
identified by the German
Government is to provide a
basis for discussions on the
need for restrictions on the
marketing and use of these
substances.
Terms of reference
The Committee on the
basis of examination of the
following report
- Assessment of the
Risks to Human Health Posed by
Certain Chemicals in Textiles,
WS Atkins, Final Report,
chapters 1 to 6
is to answer the
following two questions
1) is the reported
degree of risk sufficiently
justified by the study
2) is the study of a
good quality
Opinion
a) Is the reported
degree of risk sufficiently
justified by the study?
The Report is restricted
solely to the assessment of the
sensitisation and cancer risks
for workers and consumers posed
by 8 specific textile dyes, and
risks for consumers and the
environment posed by
trichlorobenzene.
The risk assessment from
textile dyes carried out in the
Report is based on very limited
toxicological and other data,
especially for carcinogenesis,
for which no data at all appear
to exist for 6 of the 8 dyes.
This does not allow a valid
risk assessment to be conducted
for these 6 dyes.
As regards the degrees
of risk calculated in the
Report, there are serious
deficiencies in the assessment
i) For the consumers,
the conclusion that cancer
risks from skin contact are
likely to be within acceptable
levels for textiles with dye
fastness 4 or more can only be
applied to Disperse Blue I and
Disperse Yellow 3. No
conclusions can be drawn
regarding the remaining dyes
because of lack of relevant
data. Furthermore, the
important question of cancer
risks from oral ingestion
(through mouth contact with
textiles) of any of the 8 dyes
is not addressed in the Report.
The conclusion in the
Report that the risk of skin
sensitisation is likely to be
low for textiles with dye
fastness 4 or more is not based
on scientifically sound
methodology. The currently
available evidence raises some
concern that an unacceptably
high level of risk may exist.
ii) As for workers, skin
exposure is calculated through
modelling to be above the level
leading to an unacceptably high
cancer risk for Disperse Blue
I, although this conclusion is
not clearly stated in the
Report. While it is recognised
that modelling may overestimate
exposure, the possibility that
an unacceptably high level of
risk exists cannot be excluded.
These conclusions apply only to
the above-mentioned dye and
cannot be extended to any of
the other seven dyes because no
appropriate data are available.
Furthermore, the question of
cancer risks from dye
inhalation by workers is not
addressed in the Report.
In the case of
consumers, the quantitative
calculations leading to the
Report's conclusion that the
risk of skin sensitisation is
likely to be low for textiles
with dye fastness 4 or more is
not based on scientifically
sound methodology. However, the
very limited available
epidemiological evidence
suggests that such risks are
indeed low.
For the assessment of
risks from trichlorobenzene,
the Report's focus on risks to
consumers experiencing dermal
exposure, and the conclusion
that risks are likely to be
low, is justified.
b) Is the report of a good
quality?
There are serious
deficiencies regarding the
overall quality of the Report.
It is noted for example that
i) No information on:
the chemical structures, the
physicochemical properties or
the impurities of the dyes is
given, even though such
information is available, at
least for some of the dyes in
question; such an omission is
totally unacceptable;
ii) Despite the scarcity
of carcinogenicity data, no use
of genotoxicity data,
structure-activity
relationships (SAR) or other
important supporting
experimental data is made to
aid with the assessment of the
carcinogenic potential of the
dyes. Moreover, cancer risk
estimates based on data for one
specific dye are generalised to
all the other dyes, something
which is not scientifically
justified.
iii) Information on
endpoints other than
sensitisation and
carcinogenicity has not been
addressed. This is only
appropriate if there is
evidence that these are the
only endpoints of concern for
each dye.
iv) The report only
considers the toxicity of the
dyes through dermal contact:
the scenario of young children
sucking or chewing dyed
textiles is not addressed.
A. DYES
1. Introduction
The Report addresses the
question of risks for human
health (specifically for
workers and consumers) posed by
8 disperse dyes used on
fabrics, namely Disperse Blue
1, 35, 106 and 124, Disperse
Red 1, Disperse Yellow 3 and
Disperse Orange 3 and 37. These
dyes are bound to the fabric by
physical forces only. The
Report focuses only on risks of
sensitisation and
carcinogenicity, apparently
after consultation with EU
authorities, on the basis of
these effects being the main
concerns.
Available animal
toxicity data appear to be
limited to results of tests on
the sensitising potential of
all 8 dyes, carcinogenicity
data for two, and acute
toxicity data for four dyes. No
information on the chemical
structures, physicochemical
properties, composition and
impurities of the considered
dyes is contained in the
Report, apparently because of
difficulties related to the use
of Colour Index nomenclature.
The CSTEE notes that such
information is available at
least for some of the dyes, and
its omission from the Report
very seriously weakens the
toxicological assessment that
follows, particularly in view
of the limited amount of
toxicity data available. For
the same reason, the complete
absence from the Report of any
reference to genotoxicity test
data (which is certainly
available for at least some of
the dyes) constitutes a serious
omission.
2. Sensitisation: Hazard
assessment and dose-response
relationships
Only skin sensitisation is considered. Results from 4 different animal sensitisation tests show that all the dyes considered are positive in at least 2 tests, leading to the conclusion that they all have a sensitisation potential. However, the absence of dose-response information from these tests makes the identification of a NOEL impossible and complicates any attempt at a risk assessment. One approach to overcoming the problems inherent in the risk assessment of sensitising agents, suggested by ETAD and adopted in the Report, utilises the relatively detailed quantitative information available in animals and humans for the strong sensitiser Kathon CG (a microbiocide). Dose-response studies with large numbers of human volunteers suggest a threshold for the induction of skin sensitisation by Kathon CG of 1.43 microg/cm2 in man, while analogous studies in animals suggest a threshold of 2.5 microg/cm2. By comparison, the animal thresholds for the considered dyes are said to be between 0.23 mg/cm2 and 25 mg/cm2, i.e. the dyes appear to be 100-1000 times less potent than Kathon CG as initiators of skin sensitisation. The potential of the dyes to elicit a response in individuals with pre-existing sensitisation to the same or related chemicals is not addressed. Based on this limited information, it is concluded that human exposures to the considered dyes below the NOEL for Kathon CG are unlikely to present any risk to most people.
In the absence of
adequate data, the above
argument may serve as a
pragmatic approach for the
estimation of relative risks
within a homologous series of
compounds. However, its use
with structurally unrelated
chemicals (Kathon CG is a
thiazolinone derivative,
completely unrelated to
anthraquinone- or azo- dyes)
and without any information on
the mechanisms by which the
chemicals being compared bring
about their effects, entails a
high degree of uncertainty and
cannot be considered as
scientifically sound.
An additional weakness
of the above argument is
related to the estimation of
the animal sensitisation
potency of the dyes. The
sensitisation potential of the
dyes was assessed typically in
maximisation tests involving a
single dose level. Where
multi-dose level tests were
employed, responses were
sometimes observed even at the
lowest level employed, i.e.
they were above the no-effect
threshold. Hence the estimation
of dye potency relative to
Kathon may not be valid.
3. Carcinogenicity:
Hazard assessment and
dose-response relationships
Some of the dyes are
stated to be azo- or
anthraquinone dyes. The
chemical names and structures
are not set out in the Report.
However, it is the CSTEE's
understanding that none of them
belongs to the group of azo
dyes capable of releasing
carcinogenic amines. As already
mentioned, carcinogenicity
bioassay data are available
only for 2 of the considered
dyes. Disperse Yellow 3 (an azo
dye) has been considered by
IARC in 1990 to show limited
evidence of carcinogenicity in
animals (induction of liver
nodules and adenomas in female
rats and mice, respectively, in
an NTP bioassay) and classified
in Group 3 (not classifiable as
to its carcinogenicity in
humans). A poorly reported
study has suggested that the
dye is mutagenic in bacteria.
Disperse Blue I (an anthraquinone derivative) has been classified by IARC as a Group 2B carcinogen (sufficient evidence of carcinogenicity in animals, possibly carcinogenic in humans) on the basis of clear induction of rat bladder tumours in an NTP bioassay. These tumours were induced only at the highest dose (5,000 ppm in diet) and correlated with the appearance of bladder calculi, suggesting a possible non-genotoxic origin. On this basis a calculation of a threshold for man at 45-56 microg/kg.day (including a safety factor of 1000) was made. On the other hand, the dye is clearly mutagenic in bacteria and for this reason the possibility of a genotoxic mechanism of cancer induction cannot be excluded. For this reason it would seem prudent to employ a linearised multistage model for carcinogenic risk assessment, although a mechanism as yet unproven of calculi formation resulting in possible erosion and cell proliferation could imply non-linearity. The linearised multistage approach has been employed by the USEPA, which has calculated lifetime risks of 10-5 and 10-6 for exposures of 3.9 and 0.39 microg/kg.day, respectively.
No carcinogenicity data
on the remaining dyes are
available. No review of
genotoxicity or other
supporting data is included in
the Report, nor is any attempt
at using SAR made.
4. Other health effects
LD50 values are
available for four of the
considered dyes. All are over
2000 mg/kg, indicating a low
acute toxicity. No other data
appear to be available.
5. Occupational exposure
and disease data
Only dermal exposure is
assessed in the Report. It is
noted that inhalation is a
likely route of worker exposure
during dye manufacture, and the
possible risks associated with
it cannot be ignored,
particularly in view of the
carcinogenic potential of at
least some of the dyes.
No occupational exposure
measurements or monitoring data
appear to be available from the
dye manufacturing or textile
dyeing industries.
Consequently, exposures have
been calculated using the EASE
model and, for both industries,
dermal exposures in the range
0.1-1 mg/cm2.day are estimated.
While such exposures are likely
to be a serious overestimate,
(the EASE model does not take
into consideration the use of
personal protective equipment),
comparison with the USEPA
carcinogenicity unit risk
estimate for Disperse Blue 1
suggests that some
carcinogenicity risks might be
present. This conclusion only
applies to that particular dye
and there is no basis for
extending it to the remaining
dyes. No occupational
epidemiology data related to
the carcinogenicity of the
considered dyes appear to be
available.
No reliable assessment
of the corresponding
sensitisation risks can be
made. If the comparison with
the sensitisation NOEL of
Kathon CG, adopted in the
Report, is made, it leads to
the conclusion that a
significant risk for workers
may exist. On the other hand,
occupational disease data from
industry surveys and an
occupational skin disease
database indicate that cases of
occupational dermatitis
associated with the manufacture
and application of textile dyes
are rarely reported from which
the report concludes that no
significant sensitisation risk
exists. Although airborne
dispersal of these dyes may
occur in the workplace no
consideration is given in the
Report to possible respiratory
sensitisation.
6. Consumer exposure and
disease data
Although consumer
exposure to textile-associated
dyes may be dermal and oral,
the Report discusses only
dermal exposure because of the
dyes' low acute toxicity. The
CSTEE notes that oral exposure
of children sucking dyed
garments might result in
substantial oral exposures,
and, in view of the possible
carcinogenicity and other
risks. It is therefore
essential that this route be
considered.
The main factors
determining dye release from
textiles to the skin, include
the type of dyed textile,
contact with other substrates
(skin, other textiles), "dye
depth" (amount of dye mix per
mass of garment) and number of
previous washings. Quantitative
release data from studies
carried out by ETAD are
presented in the Report,
without a critical assessment
of the methodology used for
their generation. Two exposure
scenarios are considered:
a) A "sufficient
fastness" scenario assumes a
new and previously unwashed,
close-fitting garment with a
dye perspiration fastness of 4
(considered in the textile
industry to be a good level of
fastness, apparently achieved
by all the considered dyes on
all commonly employed
textiles). Based on
experimental release data, this
scenario predicts a release to
the skin of 0.03 microg/cm2
(the time period over which
this release takes place is not
clarified but appears to
correspond to the time of
normal daily use of a garment,
i.e. per day). In the absence
of suitable quantitative data,
it is not possible to assess
the skin sensitisation risk
which this exposure presents.
For the calculation of
carcinogenic risks, a figure of
0.007 microg/cm2.day, based on
ETAD tests of dye
extractability from textiles,
is used as the average skin
exposure arising from the use
of a garment of fastness 4 over
its lifetime. Assuming full
absorption of the dye, this
corresponds to a systemic
exposure of 1 microg/kg.day for
a 70 kg adult, which is roughly
fiftyfold lower than the
assumed threshold level (45-56
microg/kg.day) and fourfold
lower than the 10-5 risk level
(3.9 microg/kg.day) for
Disperse Blue 1.
b) A "worst case"
scenario assumes a
close-fitting nylon garment (a
material with relatively poor
fastness properties) dyed
heavily to a "dye depth" of 8
(in contrast to the more usual
1% which is associated with
fastness 4). This scenario
leads to a predicted exposure
of 6.1 microg/cm2.day which
suggesting that garments with
dye depth above 8
(corresponding to fastness
level below 4) may pose
carcinogenic risks.
The Report concludes
that textiles dyed to fastness
of 4 or above do not pose any
significant health risks. The
CSTEE notes that a) these
conclusions are only likely
valid for cancer risks from
Disperse Blue I, and probably
the less carcinogenic Disperse
Yellow 3, but they cannot be
extrapolated to the other dyes,
and b) no quantitative
estimation of the sensitisation
risks is possible.
Α detailed review of the literature (case reports and incidence studies) on sensitisation appears to have been carried out by the Report's authors. According to the results of this review, during the period 1965-98, approximately 10-15 cases per year of skin sensitisation to the dyes under discussion were reported, their trend in time being relatively constant. The authors conclude that, having in mind the large number of people who probably come in contact with dyed garments, sensitisation to the specific dyes is a rare occurrence in the general population. However, it should be noted that the probability of a case of dye sensitisation, being recognised as such and considered by clinicians of sufficient interest to be published in the scientific literature, is likely to be small and that the true incidence may be much higher. This finds some support in the Report's conclusions regarding published incidence surveys, i.e. studies based on random patch-testing of subjects at dermatology clinics. A significant number of such studies report that 1-3% (sometimes as many as 10.1%) of all individuals tested give a positive skin reaction to the considered dyes, an incidence which is clearly well above the tolerable limit. The hypothesis that this reaction is the result of cross-sensitisation, i.e. that these individuals suffered primary sensitisation to another dye is suggested. P-phenylenediamine, a sensitising dye widely used in hair dyes is mentioned as a possible primary sensitiser. While such a possibility cannot be excluded, no specific evidence to support it has been put forward. Furthermore, cross-sensitisation would be expected to operate between structurally-related chemicals. The high incidence of sensitisation to the considered dyes among the general population, in combination with their known sensitising potential, raises the possibility that these dyes may present an unacceptable risk of sensitisation for consumers.
7. Conclusions
The Report concludes
that
a. for workers, despite
the high skin exposure
calculated through modelling,
sensitisation risks are likely
to be within acceptable limits
based on the limited evidence
from occupational health
surveys. This is a reasonable
conclusion. The Report does not
state any specific conclusion
regarding cancer risks. Based
on the modelled exposures, such
risks would be expected to be
significant for Disperse Blue
I, while no conclusions can be
drawn regarding the other seven
dyes. Furthermore, the question
of cancer risks from dye
inhalation by workers is not
addressed in the Report.
b. for consumers, it is
assumed that no significant
initiation of sensitisation or
cancer risks will arise from
dermal contact with textiles
dyed to fastness of 4 or above.
This conclusion is appropriate
only for carcinogenic risks
arising from Disperse Blue I,
while for skin sensitisation,
no quantitative estimates can
be made. However, the proven
sensitising potential of the
dyes and the high incidence of
sensitisation to them observed
among the general population
raises concern that such a risk
may exist. The risk from the
oral exposure route for young
children needs to be
considered.
B. TRICHLOROBENZENE
The Report reviews in a
separate chapter the risks to
consumer health and the
environment posed by TCB in
textiles. Occupational exposure
is not considered because this
agent is no longer used in the
European textile dyeing
industry.
Toxicity data are very
briefly mentioned and the
conclusions of the hazard and
risk assessments made by other
authorities (WHO, RIVM, German
competent authority) are
presented. WHO and RIVM
concluded in 1991 that provided
appropriate care is taken,
health hazards are minimal.
Following a "worst case"
scenario exposure assessment,
the German competent authority
concluded in 1997 that a 2.7
safety margin exists. The
Report correctly suggests that
this safety margin is likely to
be much higher in the case of
textiles finished according to
state-of-the-art technology,
which are likely to have an
approximately 10fold lower TCB
content than that assumed in
the exposure scenario. It is
also pointed out, on the other
hand, that this assumption may
not hold for imported garments.
As regards environmental
effects of TCB, based on a
brief review of the literature
and information from an RIVM
report, PNEC values for aquatic
and terrestrial organisms are
derived. In view of the absence
of data on TCB release from
textiles to the environment,
historical data on TCB
concentrations in surface
waters are presented which show
a decreasing trend during the
1980's when TCB was more
commonly used than it is
nowadays. These data indicate
that TCB concentrations were
then below the PNEC values and
it is thus suggested that they
are unlikely to present any
problem today.
-